Virtual screening and assessment of anticancer potential of selenium-based compounds against HL-60 and MCF7 cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Sanmartin C, Plano D, Palop JA. Selenium compounds and apoptotic modulation: a new perspective in cancer therapy. Mini Rev. Med. Chem. 8(10), 1020–1031 (2008). • Describes epidemiological data on cancer worldwide.
  Medline CASGoogle Scholar
• 2. Sanmartín C, Plano D, Sharma AK, Palop JA. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Int. J. Mol. Sci. 13(8), 9649–9672 (2012).
  Medline CASGoogle Scholar
• 3. Forman D, Ferlay J, Stewart BW, Wild CP. The global and regional burden of cancer. World Cancer Rep. 1, 16–53 (2014).
  Google Scholar
• 4. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 166(5), 1069–1080 (2012).
  Medline CASGoogle Scholar
• 5. Murad AM, Katz A. Oncologia: Bases Clínicas do Tratamento. Guanabara, Rio de Janeiro, Brazil, 41–42 (1996).
  Google Scholar
• 6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
  Medline CASGoogle Scholar
• 7. Bonassa EMA, Gato MIR. Terapêutica Oncológica Para Enfermeiros e Farmacêuticos. Atheneu, São Paulo, Brazil, 644–645 (2012).
  Google Scholar
• 8. Siegel R, DeSantis C, Virgo K et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J. Clin. 62(4), 220–241 (2012).
  MedlineGoogle Scholar
• 9. Kumar R, Kaur M, Silakari O. Physiological modulation approaches to improve cancer chemotherapy: a review. Anticancer Agents Med. Chem. 14(5), 713–749 (2014). • Describes studies that report antitumor activity of some compounds containing selenium.
  Medline CASGoogle Scholar
• 10. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Rev. Environ. Health 16(4), 233–260 (2001).
  Medline CASGoogle Scholar
• 11. Chen Y-C, Prabhu KS, Mastro AM. Is selenium a potential treatment for cancer metastasis? Nutrients 5(4), 1149–1168 (2013).
  MedlineGoogle Scholar
• 12. Margaret PR. Selenium and human health. Lancet 379(9822), 1256–1268 (2012).
  MedlineGoogle Scholar
• 13. Weekley CM, Aitken JB, Finney L, Vogt S, Witting PK, Harris HH. Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems. Nutrients 5(5), 1734–1756 (2013).
  Medline CASGoogle Scholar
• 14. Rahden-Staroń I, Suchocki P, Czeczot H. Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 699(1–2), 44–46 (2010). • Addresses the importance of computer-aided drug design in the development of new drugs.
  CASGoogle Scholar
• 15. Mangiatordi GF, Trisciuzzi D, Alberga D et al. Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoprotein. Eur. J. Med. Chem. 139, 792–803 (2017).
  Medline CASGoogle Scholar
• 16. Trisciuzzi D, Alberga D, Mansouri K et al. Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data. Future Med. Chem. 7(14), 1921–1936 (2015).
  CASGoogle Scholar
• 17. Scotti L, Scotti MT. In silico studies applied to natural products with potential activity against Alzheimer's disease. In: Computational Modeling of Drugs Against Alzheimer’s Disease. Springer, NY, USA, 513–531 (2018).
  Google Scholar
• 18. Scotti L, Júnior FJBM, Ishiki HM et al. Computer-aided drug design studies in food chemistry. In: Natural and Artificial Flavoring Agents and Food Dyes. Elsevier, MA, USA, 261–297 (2018).
  Google Scholar
• 19. Silva LM, Alves MF, Scotti L, Lopes WS, Scotti MT. Predictive ecotoxicity of MoA 1 of organic chemicals using in silico approaches. Ecotoxicol. Environ. Saf. 153, 151–159 (2018). •• Describes the synthetic methodology and data that helped characterize the compounds used in the study.
  MedlineGoogle Scholar
• 20. Luis JAS, Souza HDS, Lira BF et al. Combined structure-and ligand-based virtual screening aiding discovery of selenoglycolicamides as potential multitarget agents against Leishmania species. J. Mol. Struct. 1198, 126872 (2019). •• Describes methodologies of good practice in data curation for use in virtual screening.
  CASGoogle Scholar
• 21. Fourches D, Muratov E, Tropsha A. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J. Chem. Inf. Model. 50(7), 1189–1204 (2010).
  Medline CASGoogle Scholar
• 22. Fourches D, Muratov E, Tropsha A. Curation of chemogenomics data. Nat. Chem. Biol. 11(8), 535–535 (2015).
  Medline CASGoogle Scholar
• 23. Fourches D, Muratov E, Tropsha A. Trust, but verify II: a practical guide to chemogenomics data curation. J. Chem. Inf. Model. 56(7), 1243–1252 (2016).
  Medline CASGoogle Scholar
• 24. Muratov EN, Artemenko AG, Varlamova EV et al. Per aspera ad astra: application of Simplex QSAR approach in antiviral research. Fut. Med. Chem. 2(7), 1205–1226 (2010).
  CASGoogle Scholar
• 25. Breiman L. Random forests. Mach. Learn. Springer, USA, 45(1), 5–32 (2001).
  Google Scholar
• 26. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: an update. SIGKDD Explor. 11(1), 10–18 (2009).
  Google Scholar
• 27. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1), 29–36 (1982). •• Relevant works to elucidate the results obtained in our in vitro studies of anticancer activity.
  Medline CASGoogle Scholar
• 28. Maciag JJ, Mackenzie SH, Tucker MB, Schipper JL, Swartz P, Clark AC. Tunable allosteric library of caspase-3 identifies coupling between conserved water molecules and conformational selection. Proc. Natl Acad. Sci. 113(41), E6080–E6088 (2016).
  Medline CASGoogle Scholar
• 29. Blanchard H, Kodandapani L, Mittl PRE et al. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure 7(9), 1125–1133 (1999).
  Medline CASGoogle Scholar
• 30. Witkowski WA, Hardy JA. L2′ loop is critical for caspase-7 active site formation. Protein Sci. 18(7), 1459–1468 (2009).
  Medline CASGoogle Scholar
• 31. Onodera K, Satou K, Hirota H. Evaluations of molecular docking programs for virtual screening. J. Chem. Inf. Model. 47(4), 1609–1618 (2007).
  Medline CASGoogle Scholar
• 32. Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem. 49(11), 3315–3321 (2006).
  Medline CASGoogle Scholar
• 33. Riss TL, Moravec RA, Niles AL et al. Cell viability assays. In: Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences (2016).
  Google Scholar
• 34. Mousinho KC. Estudo do potencial anticâncer de um derivado de Chalcona, 1-(4-Nitrofenil)-3-Fenilprop-2-En-1-Ona, in vitro e in vivo. Master Dissertation 1, 170 (2010).
  Google Scholar
• 35. Liu K, Liu P-c, Liu R, Wu X. Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med. Sci. Monit. 21, 15 (2015).
  Google Scholar
• 36. Perelman A, Wachtel C, Cohen M, Haupt S, Shapiro H, Tzur A. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 3, e430 (2012).
  Medline CASGoogle Scholar
• 37. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 64(4), 527–542 (2005).
  Medline CASGoogle Scholar
• 38. Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, Lee CC. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 42(4), 377–387 (2007).
  Medline CASGoogle Scholar
• 39. Fernandes AP, Gandin V. Selenium compounds as therapeutic agents in Cancer. Biochim. Biophys. Acta 1850(8), 1642–1660 (2015).
  Medline CASGoogle Scholar
• 40. Mishra T, Khullar M, Bhatia A. Anticancer potential of aqueous ethanol seed extract of Ziziphus mauritiana against cancer cell lines and Ehrlich ascites carcinoma. Evid. Based Complement. Alternat. Med. e-pub (2011).
  MedlineGoogle Scholar
• 41. Riul S, Aguillar OM. Quimioterapia antineoplásica: revisão da literatura. Rev. Min. Enferm. 3(1/2), 60–67 (1999).
  Google Scholar
• 42. Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589–598 (2001).
  Medline CASGoogle Scholar
• 43. Kroemer G, Galluzzi L, Vandenabeele P et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16(1), 3–11 (2009).
  Medline CASGoogle Scholar
• 44. Liu J-j, Lin M, Yu J-y, Liu B, Bao J-k. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 300(2), 105–114 (2011).
  Medline CASGoogle Scholar
• 45. Gabel-Jensen C, Lunøe K, Gammelgaard B. Formation of methylselenol, dimethylselenide and dimethyldiselenide in in vitro metabolism models determined by headspace GC-MS. Metallomics 2(2), 167–173 (2010).
  Medline CASGoogle Scholar
• 46. Wu M, Kang MM, Schoene NW, Cheng W-H. Selenium compounds activate early barriers of tumorigenesis. J. Biol. Chem. 285(16), 12055–12062 (2010).
  Medline CASGoogle Scholar
• 47. Degli Esposti M. Mitochondria in apoptosis: past, present and future. Biochem. Soc. Trans. 32(3), 493–495 (2004).
  MedlineGoogle Scholar
• 48. Fairweather-Tait SJ, Bao Y, Broadley MR et al. Selenium in human health and disease. Antiox. Redox Sign. 14(7), 1337–1383 (2011).
  Medline CASGoogle Scholar
• 49. Lopez J, Tait SWG. Mitochondrial apoptosis: killing cancer using the enemy within. Br. J. Cancer 112(6), 957–962 (2015).
  Medline CASGoogle Scholar
• 50. Peng Z-f, Lan L-x, Zhao F et al. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells. J. Zhejiang Univ. Sci. B 9(1), 16–21 (2008).
  Medline CASGoogle Scholar
• 51. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. 9(1), 47–59 (2008).
  Medline CASGoogle Scholar
• 52. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology 7(3), 253–266 (1973).
  Medline CASGoogle Scholar
• 53. Vercammen D, Vandenabeele P, Beyaert R, Declercq W, Fiers W. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 9(11), 801–808 (1997).
  Medline CASGoogle Scholar
• 54. Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9(17), S967–S961 (1999).
  Medline CASGoogle Scholar
• 55. Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv. Hematol. 524308 (2012).
  MedlineGoogle Scholar
• 56. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 407(6805), 810–816 (2000).
  Medline CASGoogle Scholar
• 57. Debatin K-M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. Immunother. 53(3), 153–159 (2004).
  MedlineGoogle Scholar
• 58. Gromadzińska J, Reszka E, Bruzelius K, Wąsowicz W, Åkesson B. Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur. J. Nut. 47(2), 29–50 (2008).
  Medline CASGoogle Scholar